Reversion from precore mutation to wild type in anti-HBe positive patients on lamivudine therapy.

被引：0
|
作者：
Maria, B [1 ]
Francisco, RF [1 ]
Rosendo, J [1 ]
Montse, C [1 ]
Rafael, E [1 ]
Jaume, G [1 ]
机构：
[1] Hosp Gen Valle Hebron, Barcelona, Spain
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
736
引用
收藏
页码：344A / 344A
页数：1
相关论文
共 50 条
  • [1] Prolonged Lamivudine treatment in patients with chroni active anti-Hbe positive hepatitis
    Fazio, V
    Angarano, G
    Scotto, G
    JOURNAL OF HEPATOLOGY, 2002, 36 : 128 - 128
  • [2] Lamivudine in anti-HBe positive chronic hepatitis: Clinical outcome
    Ascione, T
    Utech, W
    Macri, M
    Ascione, A
    Lanza, AG
    JOURNAL OF HEPATOLOGY, 2002, 36 : 107 - 107
  • [3] Is there any correlation between HBV genomic factors and response to lamivudine therapy in anti-HBe positive patients?.
    Buti, M
    Costa, X
    Cotrina, M
    Valdés, A
    Rodriguez, F
    Jardí, R
    Esteban, R
    Guardia, J
    HEPATOLOGY, 2001, 34 (04) : 625A - 625A
  • [4] Interferon plus lamivudine versus lamivudine monotherapy in patients with chronic hepatitis B anti-HBE positive
    Karatapanis, S
    Ketikoglou, I
    Skorda, L
    Manolakopoulos, S
    Komnianides, K
    Lisgos, F
    Psellas, C
    Kalderi, T
    Kipraios, D
    Kouvidou, C
    Spanos, E
    Artikis, V
    JOURNAL OF HEPATOLOGY, 2004, 40 : 127 - 128
  • [5] Lamivudine and lamivudine plus interferon treatment in naive anti-HBe positive patients with chronic hepatitis B
    Akarca, US
    Ersoz, G
    Gunsar, F
    Kilicsoy, N
    Karasu, Z
    Vardar, R
    Batur, Y
    JOURNAL OF HEPATOLOGY, 2001, 34 : 164 - 164
  • [6] Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study
    Santantonio, T
    Niro, GA
    Sinisi, E
    Leandro, G
    Insalata, M
    Guastadisegni, A
    Facciorusso, D
    Gravinese, E
    Andriulli, A
    Pastore, G
    JOURNAL OF HEPATOLOGY, 2002, 36 (06) : 799 - 804
  • [7] Extended lamivudine treatment in patients affected by chronic active anti-Hbe positive hepatitis
    Scotto, G
    Palumbo, E
    Fazio, V
    Saracino, A
    Angarano, G
    JOURNAL OF CHEMOTHERAPY, 2006, 18 (01) : 43 - 48
  • [8] The natural history of anti-HBE positive (precore mutant) chronic hepatitis B patients.
    Lee, YM
    Wai, DCT
    Lim, LL
    Dong, P
    Perumal, V
    Chung, CK
    Lim, TP
    Ho, I
    Yeoh, KG
    Ho, KY
    Lim, SG
    HEPATOLOGY, 2000, 32 (04) : 575A - 575A
  • [9] Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients
    Nikolaidis, NL
    Giouleme, OI
    Tziomalos, KA
    Saveriadis, AS
    Grammatikos, N
    Doukelis, P
    Voutsas, AD
    Vassiliadis, T
    Patsiaoura, K
    Orfanou-Koumerkeridou, E
    Balaska, A
    Eugenidis, NP
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (11) : 1721 - 1725
  • [10] APPEARANCE OF HBEAG/ANTI-HBE COMPLEXES IN ANTI-HBE POSITIVE PATIENTS WITH REACTIVATION OF VIRAL REPLICATION
    CASTILLO, I
    BARTOLOME, J
    LABANDA, F
    MORA, I
    PORRES, JC
    HERNANDEZGUIO, C
    CARRENO, V
    JOURNAL OF HEPATOLOGY, 1988, 6 (03) : P6 - P7
12345